Heart check revolution: new models may spare thousands from unneeded scans

NCT ID NCT06708000

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether personalized risk models can safely reduce the number of diagnostic tests for people with new chest pain. Researchers will enroll 2,000 adults aged 30-75 and compare the model-based approach to standard care. They will also test a new laser method to measure blood flow in tiny vessels. The goal is to see if patients stay symptom-free and avoid unnecessary procedures.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Clinical Likelihood (CL) Model-Based Diagnostic Strategy
What this could lead to
If successful, this could help doctors use fewer invasive tests for chest pain, saving time and discomfort for many patients.
What could go wrong
This is a large Phase 3 trial, but the approach may not be accurate for all patient groups, and the new laser test is still experimental.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANGINA PECTORIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Regional Hospital of Godstrup

    Herning, 7400, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.